{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:55:32Z","timestamp":1778511332665,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bioorg.2023.107003","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T07:09:21Z","timestamp":1700896161000},"page":"107003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["New thiophene-1,3,4-oxadiazole-thiazolidine-2,4-dione hybrids: Synthesis, MCF-7 inhibition and binding studies"],"prefix":"10.1016","volume":"143","author":[{"given":"Manasa A.","family":"Doddagaddavalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerendra Kumar A.","family":"Kalalbandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaldappagari","family":"Seetharamappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrinivas D.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.107003_b0005","first-page":"1","author":"Stanis\u0142awek","year":"2021","journal-title":"Breast Cancer\u2014Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies\u2014 An Updated Review"},{"key":"10.1016\/j.bioorg.2023.107003_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","article-title":"Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis","volume":"5","author":"Feng","year":"2018","journal-title":"Genes Dis."},{"key":"10.1016\/j.bioorg.2023.107003_b0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/CPath.S31563","article-title":"Diversity of breast carcinoma: Histological subtypes and clinical relevance","volume":"8","author":"Makki","year":"2015","journal-title":"Clin. Med. Insights Pathol."},{"key":"10.1016\/j.bioorg.2023.107003_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119305","article-title":"Molecular docking, synthesis and anticancer activity of thiosemicarbazone derivatives against MCF-7 human breast cancer cell line","volume":"273","author":"Sibuh","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2023.107003_b0025","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: An overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2023.107003_b0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14656566.2014.868884","article-title":"Raltegravir as antiretroviral therapy in HIV\/AIDS","volume":"15","author":"Sharma","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2023.107003_b0035","first-page":"5727","article-title":"1,3,4-oxadiazole as a potential anti-cancer scaffold: A review","volume":"12","author":"Alam","year":"2022","journal-title":"Biointerface Res. Appl. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0040","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.bmc.2017.05.054","article-title":"1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities","volume":"25","author":"Thakkar","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0045","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1200\/JCO.2012.46.4149","article-title":"Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer","volume":"31","author":"Fizazi","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2023.107003_b0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bioorg.2017.05.007","article-title":"Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives","volume":"73","author":"Naim","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0055","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1021\/jm00049a017","article-title":"[[\u03c9-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as Potent Antihyperglycemic Agents","volume":"37","author":"Cantello","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106235","article-title":"Coumarin-4-yl-1,2,3-triazol-4-yl-methyl-thiazolidine-2,4-diones: Synthesis, glucose uptake activity and cytotoxic evaluation","volume":"130","author":"Metre","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0065","first-page":"96","article-title":"Synthesis, Characterization of 2,4 -Thiazolidinedione Derivatives and Evaluation of Their Antioxidant Activity","volume":"3","author":"Shahnaz","year":"2013","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.bioorg.2023.107003_b0070","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1016\/S0960-894X(98)00485-5","article-title":"Synthesis and biological activity of novel thiazolidinediones, Bioorganic Med","volume":"8","author":"Prabhakar","year":"1998","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.107003_b0075","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1016\/j.bmcl.2009.05.126","article-title":"Synthesis and antitumor activity of substituted triazolo[4,3-a]pyrimidin-6-sulfonamide with an incorporated thiazolidinone moiety, Bioorganic Med","volume":"19","author":"Hafez","year":"2009","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.107003_b0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejmech.2013.10.005","article-title":"Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring","volume":"70","author":"Chinthala","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103569","article-title":"Synthesis of a novel series of (Z)-3,5-disubstituted thiazolidine-2,4-diones as promising anti-breast cancer agents","volume":"96","author":"El-Kashef","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph15020226","article-title":"Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPAR\u03b3 Agonists","volume":"15","author":"Abdelgawad","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2023.107003_b0095","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.bmcl.2010.08.130","article-title":"Novel thiazolidinedione derivatives with anti-obesity effects: Dual action as PTP1B inhibitors and PPAR-\u03b3 activators","volume":"20","author":"Bhattarai","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.107003_b0100","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.bmcl.2009.03.026","article-title":"Synthesis of novel thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline as potent antimalarials","volume":"19","author":"Sunduru","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.107003_b0105","first-page":"2151","article-title":"Synthesis and preliminary evaluation of some pyrazine containing thiazolines and thiazolidinones as antimicrobial agents, Bioorganic","volume":"12","author":"Bonde","year":"2004","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/22113525113119990117","article-title":"Synthesis and Evaluation of N-Substituted Thiazolidine-2,4-dione Containing Pyrazole as a Potent Antimicrobial Agents","volume":"12","author":"Desai","year":"2014","journal-title":"Anti-Infective Agents"},{"key":"10.1016\/j.bioorg.2023.107003_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2021.101284","article-title":"1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships","volume":"25","author":"Nayak","year":"2021","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bioorg.2023.107003_b0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10637-017-0537-x","article-title":"Contribution of reactive oxygen species to the anticancer activity of aminoalkanol derivatives of xanthone","volume":"36","author":"Sypniewski","year":"2018","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.bioorg.2023.107003_b0125","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/12\/6\/066007","article-title":"Role of endocytosis in sonoporation-mediated membrane permeabilization and uptake of small molecules: A electron microscopy study","volume":"12","author":"Zeghimi","year":"2015","journal-title":"Phys. Biol."},{"key":"10.1016\/j.bioorg.2023.107003_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134625","article-title":"Synthesis, characterization, crystallographic, binding, in silico and antidiabetic studies of novel 2,4-thiazolidinedione-phenothiazine molecular hybrids","volume":"1276","author":"Doddagaddavalli","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2023.107003_b0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1134\/S0022476623010092","article-title":"Characterization, Crystal Structure, Anticancer and Antioxidant Activity of Novel N-(2-Oxo-2-(10H-Phenothiazin-10-Yl) Ethyl)Piperidine-1-Carboxamide","volume":"64","author":"Doddagaddavalli","year":"2023","journal-title":"J. Struct. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bioorg.2023.107003_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111394","article-title":"BODIPY-based monofunctional Pt (II) complexes for specific photocytotoxicity against cancer cells","volume":"218","author":"Qi","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2023.107003_b0150","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1039\/D2OB00372D","article-title":"Fluorescent annulated imidazo[4,5-c]isoquinolines via a GBB-3CR\/imidoylation sequence - DNA-interactions in pUC-19 gel electrophoresis mobility shift assay","volume":"20","author":"Stahlberger","year":"2022","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijbiomac.2015.03.036","article-title":"Spectroscopic and molecular docking studies on the interaction of troxerutin with DNA","volume":"78","author":"Subastri","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2023.107003_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molliq.2017.10.017","article-title":"Deciphering the interaction of methotrexate with DNA: Spectroscopic and molecular docking study","volume":"248","author":"Yang","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2023.107003_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2022.952297","article-title":"Development of new bioactive molecules to treat breast and lung cancer with natural myricetin and its derivatives: A computational and SAR approach","volume":"12","author":"Akash","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2023.107003_b0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: The rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bioorg.2023.107003_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.104966","article-title":"Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"136","author":"Guo","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2023.107003_b0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1107\/S2059798317015121","article-title":"An introduction to experimental phasing of macromolecules illustrated by SHELX; New autotracing features","volume":"74","author":"Us\u00f3n","year":"2018","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"10.1016\/j.bioorg.2023.107003_b0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. C Struct. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2023.107003_b0195","unstructured":"S. Bruker, and SAINT-plus (Version 6.45 A), Bruker AXS Inc, Madison, Wisconsin, USA. (2014)."},{"key":"#cr-split#-10.1016\/j.bioorg.2023.107003_b0200.1","unstructured":"G.M. Sheldrick, XS. version 2013\/1, Georg-August-Universit\u00e4t G\u00f6ttingen, Germany, 2013"},{"key":"#cr-split#-10.1016\/j.bioorg.2023.107003_b0200.2","doi-asserted-by":"crossref","unstructured":"b) GM Sheldrick, Acta Crystallogr., Sect. A. 71 (2015) 3-8.","DOI":"10.1107\/S2053273314026370"},{"key":"10.1016\/j.bioorg.2023.107003_b0205","first-page":"394","article-title":"Selective inhibition of \u03b2-N-acetylhexosaminidases by thioglycosyl\u2013naphthalimide hybrid molecules, Bioorganic","volume":"26","author":"Chen","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0210","article-title":"Intercalation of a flavonoid, silibinin into DNA base pairs: Experimental and Intercalation of a flavonoid, silibinin into DNA base pairs","author":"Pawar","year":"2019","journal-title":"Experimental and Theoretical Approach"},{"key":"10.1016\/j.bioorg.2023.107003_b0215","first-page":"101","article-title":"Spectrophotometric determination of ezetimibe","volume":"7","author":"Baby Sudha Lakshmi","year":"2010","journal-title":"E-J. Chem."},{"key":"10.1016\/j.bioorg.2023.107003_b0220","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1007\/s00044-014-1013-1","article-title":"3D-QSAR and molecular docking studies of 1,3,4-oxadiazoles containing substituted phenoxy fragment as inhibitors of enoyl-acyl carrier protein reductase from Escherichia coli","volume":"23","author":"Joshi","year":"2014","journal-title":"Med. Chem. Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823006648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823006648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:49:07Z","timestamp":1758617347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823006648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":45,"alternative-id":["S0045206823006648"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.107003","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New thiophene-1,3,4-oxadiazole-thiazolidine-2,4-dione hybrids: Synthesis, MCF-7 inhibition and binding studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.107003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107003"}}